Eisai
4523.T
#2175
Rank
A$11.82 B
Marketcap
A$41.90
Share price
-1.05%
Change (1 day)
-29.88%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

P/E ratio for Eisai (4523.T)

P/E ratio as of June 2025 (TTM): 27.1

According to Eisai's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.0596. At the end of 2024 the company had a P/E ratio of 41.1.

P/E ratio history for Eisai from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202441.17.26%
202338.310.4%
202234.7171.51%
202112.8177.56%
20204.61-34.77%
20197.06-24.51%
20189.36-11.78%
201710.618.3%
20168.97-38.22%
201514.597.76%
20147.3422.61%
20135.9949.41%
20124.0127.64%
20113.14-47.42%
20105.9734.75%
20094.43-131.35%
2008-14.1-347.95%
20075.70-1.43%
20065.7822.73%
20054.7115.83%
20044.073%
20033.95-37.64%
20026.33-36.78%
200110.0

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.

OSZAR »